SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001387131-20-001273
Filing Date
2020-02-11
Accepted
2020-02-11 12:41:42
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL EQUITIES II LPVIKING GLOBAL EQUITIES MASTER LTD.VIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LPVIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLCVIKING

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP adpt-sc13g_123119.htm SC 13G 300132
  Complete submission text file 0001387131-20-001273.txt   302219
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Subject) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91363 | Film No.: 20595502
SIC: 2836 Biological Products, (No Diagnostic Substances)